David Henley Selected Research

David Henley Research Topics

6	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2014
2	Dementia (Dementias) 01/2017 - 01/2014
1	Anxiety Disorders (Anxiety Disorder) 01/2022
1	Cognitive Dysfunction 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Pre-Eclampsia (Preeclampsia) 10/2016
1	Sepsis (Septicemia) 10/2016
1	Inflammation (Inflammations) 10/2016
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 10/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Dosage-sensitive sex reversal 04/2015
1	Critical Illness (Critically Ill) 04/2015
1	Fever (Fevers) 10/2010
1	Paraganglioma (Paragangliomas) 03/2006
1	Pheochromocytoma 03/2006

5	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 10/2010
3	atabecestatIBA 01/2021 - 11/2019
3	Calcium Gluconate (CBG)IBA 10/2016 - 10/2010
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2021
2	solanezumabIBA 01/2017 - 01/2015
2	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2016 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 04/2015 - 10/2010
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2016
1	GlucocorticoidsIBA 04/2015
1	LipopolysaccharidesIBA 04/2015
1	Steroidogenic Factor 1IBA 04/2015
1	MelanocortinsIBA 04/2015
1	steroidogenic acute regulatory proteinIBA 04/2015
1	CorticosteroneIBA 04/2015
1	N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA 01/2015
1	florbetapirIBA 01/2014
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 03/2006
1	Peptides (Polypeptides)IBA 03/2006

1	Therapeutics 04/2015
1	Investigational Therapies (Experimental Therapy) 01/2014